Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: BW who wrote (5147)	6/12/2001 11:59:45 AM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

Yes, CALY, another big volume day. And in the face of a delist notice. Now it is at price parity with BIPL...I wonder what a million share day would do to the price of Biopool?? So, the big caps have "Bad Breadth" and the micro's just keep a poppin..nice to be playin both sides of the fence, and scoring... Maybe the big boyz are starting to leave for their summer in the Hamptons? ;-)

To: BW who wrote (5147)	6/12/2001 12:48:44 PM
From: Bucky Katt	Respond to of 48461

Rat-chocolate-dog SHD just made a new 52w high..This story from LU sums up the big cap swoon>> Oh, check post #2903 for that swell ratlist from almost a year ago, most of those were awesome trades, like RACN...which as fate would have it also made a new 52w high..The key is to follow the ratbuyplan, try to find the bottom... ""Lucent: Sector May Suffer 18 More Months FRANKFURT (Reuters) - The telecoms market may suffer for another 12-18 months until operators have cut their debt burdens, Ben Verwaayen, vice chairman of equipment maker Lucent Technologies was quoted telling a German newspaper on Friday. ``Only when the debt mountain has been cut will telecoms companies start to invest again and prospects for the sector improve,'' he said in an extract from an interview with the Frankfurter Allgemeine Zeitung released ahead of publication on Saturday. Lucent, the struggling equipment maker which recently dropped merger talks with France's Alcatel, is in the middle of a restructuring program which will see it sell businesses and cut thousands of jobs in an effort to stem billions of dollars in losses and cut its own massive debt burden."" DEBT MOUNTAIN is right!!!!!!! And 18 months may be a bit short. Short, get it?

To: BW who wrote (5147)	6/14/2001 10:25:49 AM
From: Bucky Katt	Read Replies (2) \| Respond to of 48461

This could be the reason for the BRLI move the past couple of months>Bio-Reference Laboratories Posts Record Profits On Record Revenues for Second Quarter Company continues to extend record growth to nine consecutive quarters ELMWOOD PARK, N.J.--(BW HealthWire)--June 14, 2001-- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI - news) reported record income of $502,501, or $.05 per share, on record revenues of $19,831,231 for the fiscal second quarter ended April 30, 2001, an increase of 22% over the second quarter FY2000 revenues of $16,286,141. The record income compared favorably to a loss of $(122,283) for the second quarter FY2000 and was the largest quarterly profit in the Company's history, excluding a one-time gain for the sale of assets. Gross Profit for the period rose 25% to $8,928,342 from $7,161,988 in the second quarter FY2000. The Company's improvement was based on organic sales growth as the second quarter FY2001 patient count increased 25% to 426,832 from 340,108 in the second quarter FY2000. During the six month period ended April 30, 2001, the net revenues increased 22% from $31,315,702 to $38,218,403, gross profit increased 25% from $13,686,106 to $17,054,790, and the Company recorded a profit of $624,530 versus a loss of $(217,848) when compared to the six month period ended April 30,2000. Patient count increased by 22% from 652,499 to 797,083 over the same six-month period. During the three month period ended April 30, 2001, Bio-Reference announced that it has executed a contract to provide the clinical laboratory work for the Eastern Pennsylvania state prisons, expanding its prison healthcare program into the state of Pennsylvania. The Company's PSIMedica business unit entered into a Master Reseller Agreement with XCARE.net to provide customers of XCARE with data analytics. The Company also announced that Morton Topfer, former Co-CEO and Vice Chairman of Dell Computer, has joined its Board of Directors and invested in Bio-Reference Laboratories. Some of the little ratdog stocks are making more profits per share than many of the over-bought big caps.......There might be a message in that........ My ORCL & LU puts looking green, the triple witch scores again..